Every round on record, with the sources behind each and the investors on them.
Aignosis provides AI-powered developmental assessments and early detection tools for child developmental delays, purchased mainly by parents and healthcare providers.
aignosis.inLinkedInJaipur, IndiaHealthtech17 people
5 sources · checked 1 time, last 1h ago
Sources agree on the round, amount, stage, date, and named investors. Rajneesh Bhandari and Amit Jain are identified as backers of Aignosis’s first 2024 round, not this round.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Seed | $417K Rs 4 crore | 2026-10-01 | Antler, Nikhil Kamath | 5 outlets. #21 in Trending |
5 sources · checked 1 time, last 1h ago [ VERIFIED · CORRECTED ] read against 4 of 5 sources
Sources agree on the round, amount, stage, date, and named investors. Rajneesh Bhandari and Amit Jain are identified as backers of Aignosis’s first 2024 round, not this round. | ||||
Aignosis builds AI-powered webcam screening tools that help parents, pediatricians and clinics spot early signs of autism and other developmental disorders in children.
Aignosis says autism screening lacks objective, rapid and scalable methods, while its standard-laptop-and-webcam workflow can produce an initial risk report in about five minutes and is intended to help children reach intervention sooner. The latest reported ₹4 crore seed round is aimed at taking that model into India's healthcare system; the company says it has already completed more than 8,000 screenings, deployed across more than 20 government primary health centres in Rajasthan, and is beginning operations across about 125 schools.
Checked against 10 sources today
Via Alexandria from FullEnrich: type, industry
Also named as backers in company research: Rajneesh Bhandari, Amit Jain, Aman Gupta, Peyush Bansal, Google for Startups Accelerator: AI First